Board of Directors

Mr. Rahul Guha is the Managing Director, and Chief Executive Officer of the Company and President of Operations at API Group.

He is a graduate of the Indian Institute of Management, Bangalore (IIM-B), and has nearly 17 years of experience at Boston Consulting Group (BCG), where he led the Health Care & Life Sciences practice.

Before joining BCG, Mr. Guha was the Co-founder and CEO of Nautilus Software and served as the Chief Technology Officer (CTO)at ValuePay.com, overseeing product development for the US market. He has extensive experience in MedTech and HealthTech andhas worked closely with multiple startups, supporting their digital incubation. With over two decades of experience in thepharmaceutical sector, he has been an active contributor to its growth and innovation.

Mr. Guha also serves as a Non-Executive Director on the Board of Nueclear Healthcare Limited, a wholly owned subsidiary of the Company.

Mr. Nishant Shah is an Independent Director of the Company.

A Fellow Member of the Institute of Chartered Accountants of India, Mr. Shah has over 12 years of experience primarily in banking andfinancial services. He has held key roles at leading global financial institutions, including Citibank and Standard Chartered. He spent 13years at JPMorgan Chase, where he served in senior leadership positions, including Head of Operating Risk for India.

Recognized as an authority in banking and finance, Mr. Shah has worked extensively with regulators and played a pivotal role inindustry-wide initiatives. Currently, he is the Managing Partner of Jackstien Practices and the CEO of Jonosfero International.

Mr. Shah has been honored with prestigious awards such as the India Award for Excellence and CEO Awards. Passionate aboutintegrating emerging technologies into risk management, he leverages advancements in Web 3.0, Machine Learning, and FinTech toenhance financial and regulatory frameworks. He is a key contributor to policy discussions and has held leadership positions in variousregulatory bodies, industry associations, and self-regulatory organizations.

He also serves as an Independent Director on the Board of Nueclear Healthcare Limited and is a Designated Partner at 9HireInternational LLP, Jonosfero International LLP, and Jackstien Practices and Consulting International LLP.

Mr. Anandh Sundar is an Independent Director of the Company.

He holds a PGDM from IIM Ahmedabad and is a fellow member of the Institute of Chartered Accountants of India, having been a rank holder at all levels. With over 14 years of experience in finance and management, he possesses expertise in corporate finance, strategy, fundraising, project management, risk management, internal audit, and insurance. He has worked with Indian companies, multinational corporations, and foreign entities and currently collaborates closely with startups.

Mr. Sundar also serves as Independent Director on the Boards of Nueclear Healthcare Limited and Cera Sanitaryware Limited.

Dr. Prapti Gilada is an Independent Director of the Company.

She is the CEO and Consultant Microbiologist at UniLabs Diagnostics. Additionally, she serves as a Consultant Microbiologist at Masina Hospital Trust and as the Infection Control Officer at the Head and Neck Cancer Institute of India.

Dr. Gilada holds a postgraduate degree in Microbiology from Seth GS Medical College and KEM Hospital. She has also completed a Fellowship in HIV and Drug-Resistant TB from UNAIDS’ CAPRISA (Centre for the AIDS Program of Research in South Africa) in Durban, South Africa.

She previously worked as:

• Consultant Microbiologist and Infection Control Officer at Prince Aly Khan Hospital (2018–2021), where she led the hospital’s COVID-19 infection control team.
• Consultant Microbiologist at Picture This by Jankharia (2018–2020).
• Consultant Microbiologist at the Group of TB Hospitals, Sewri (2016–2018), Asia’s largest TB hospital.

Dr. Gilada also serves as a Director on the Boards of Nueclear Healthcare Limited and Unison Medicare and Research Centre Private Limited.

Dr. Harshil Vora is an Independent Director of the Company.

He is a highly qualified and experienced Consultant Orthopaedic & Specialty Knee Surgeon. He holds an MBBS degree and has completed an MS in Orthopaedics. Additionally, he has undergone super-specialty training in England, where he pursued an MCh (Hip & Knee). Currently, he practices at Dr. Vora’s Orthopaedic Centre, Mumbai.

Dr. Vora has 13 years of clinical orthopaedic experience, including three years of international experience. He has worked at globally renowned centers of excellence, such as NYU Langone Medical Center, Birmingham Heartlands Hospital, Wrightington Hospital, and Cambridge University Hospital.

His professional achievements include Advanced Trauma Life Support (ATLS) certification and a gold medal from the Orthopaedic Department at Bharati Hospital, Pune. He has also received outstanding letters of recommendation from esteemed professionals in the field. Actively involved in research, he has authored scholarly articles and presented papers and posters at national and international conferences.

Dr. Vora’s expertise lies in soft tissue knee procedures and reconstructive surgeries, particularly total knee replacements.

Dr. Indumati Gopinathan is an Independent Director on the Board of the Company.

She is a postgraduate (M.D.) in Pathology and a highly reputed pathologist with ocular pathology as an area of special interest and recognized as a leading commentator on Telepathology. In addition to her medical expertise, she is a healthcare columnist for The Times of India and Healthcare Express, a leading weekly healthcare publication by the Indian Express group and is Wikipedia profiled. She has numerous peer reviewed publications to her credit.

Dr. Gopinathan is a committee member of Practising Pathologists of India and chief editor of its newsletter.

Dr Gopinathan has served as past president and Hon secretary of Indian medical Association, Chembur, 

A past Rotary club president and reviewer of Rotary global grant funded projects in Rotary, she has actively participated in numerous vocational training teams and community service programs globally through Rotary.

Mr. Gaurav Verma is a seasoned business leader with over 19 years of experience in marketing, consumer strategy and business leadership across the healthcare, food-tech and FMCG sectors. He currently serves as Chief Business Officer at API Holdings Limited (PharmEasy), where he is responsible for driving business growth, consumer strategy, and key strategic initiatives across e-pharmacy, e-diagnostics, partnerships and other healthcare initiatives of the platform business. He previously served as Chief Marketing Officer at PharmEasy, playing a key role in brand building, customer engagement and growth during a transformative phase of the business. Prior to API Holdings, he held senior leadership roles at Zomato as Chief Marketing Officer, and subsequently as Global Growth Head (Dining Out). Before Zomato, he spent over nine years at PepsiCo, where he led marketing for marquee brands such as Kurkure, Lay’s and Tropicana. He began his career with ITC and has also worked with Tata Tea Limited and Lenovo. Mr. Verma holds a Post Graduate Program in Management from the Indian Institute of Management, Bangalore, and a B.Tech in Electronics from the Indian Institute of Technology, Madras. His expertise in consumer insights, brand building and business scaling will add significant value to the Company.

Mr. Uday Patel Kadam is a seasoned business leader with over 18 years of diverse experience across healthcare, technology, telecom and financial services sectors, with strong expertise in business strategy, P&L management, operations and supply chain. He is currently associated with API Holdings Limited as Chief Operating Officer & Chief Business Officer, where he is responsible for driving business strategy, operational excellence and growth initiatives, with end-to-end accountability for key business verticals, including supply chain and procurement functions. Prior to this, he has held leadership roles at Ninjacart as Business Head – Ninja Kisaan Platform, where he played a key role in building and scaling platform-led businesses and managing large- scale supply chain operations across India. Earlier, he was associated with Bharti Airtel for over six years in various senior leadership roles across sales, marketing, finance and business operations, including Head of Sales & Distribution (Karnataka) and Chief Commercial Officer – Airtel Mumbai. He began his career with HSBC and Deutsche Bank in finance and credit risk functions. Mr. Kadam holds a Master of Business Administration (MBA) from the Indian School of Business and brings strong leadership capabilities and strategic acumen, which will be valuable to the Company.

Mr. Alok Kumar Jagnani, a Chartered Accountant, joined Thyrocare in August 2023 as the Chief Financial Officer. He brings over 20 years of post-qualification experience working with the world’s largest manufacturing and service industries. His expertise includes Finance and Procurement, Mergers & Acquisitions, Treasury, and Fund Management. Notably, he played a key role in the Vodafone-Idea merger, one of the largest transactions in the Telecom sector. Mr. Jagnani’s previous roles include significant positions at Tata Steel and Vodafone India, followed by finance controller responsibilities at Greencell Mobility, where he managed all finance operations, including accounting, MIS, FP&A, treasury, and inventory management.

He serves as a Director on the Board of

• Nueclear Healthcare Limited
• Think Health Diagnostics Private Limited
• Thyrocare Laboratories (Tanzania) Limited

Additionally, he is also a Designated Partner at Pulse Hitech Health Services (Ghatkopar)LLP and Chief Financial Officer at API Holdings Limited.